Connect for Well-being

Rohto's Recruitment and Work Style Real Report 2026: Aiming for Co-Growth of Individuals and the Company

Izumiotsu City x Rohto Pharmaceutical "Kodomo MY Mirai Ai Project": Three Eye Care Model Schools Selected

Rohto Group's proprietary ingredient, "Licorice Extract Powder (Lyconin®)," which contains the ingredient gliasperin B, has been approved as a functional food product for the first time in Japan.

Three new products from "Eu Yan Sang" will be released sequentially.

What determines whether you "like" a skincare product? A follow-up report: Exploring the relationship between changes in the feel of Gokujun and physiological indicators.

Regarding the issue of the old DRX brand website URL being redirected to a fraudulent site.

Initiatives to Ensure Safety in Cell Therapy

Notice of changes to packaging specifications due to environmental considerations

Publication of "Rohto Health White Paper 2025"

Please purchase from authorized Obagi retailers.

The winners of the 31st ROHTO AWARD research grants have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

We are pleased to announce the 19th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

The 16th recipients of the Rohto Women's Health Science Research Award have been announced